BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sheppard J, Garg S, Lievens C, Brandano L, Wirostko B, Korenfeld M, Raizman M, Foster CS. Iontophoretic Dexamethasone Phosphate Compared to Topical Prednisolone Acetate 1% for Noninfectious Anterior Segment Uveitis. Am J Ophthalmol 2020;211:76-86. [PMID: 31726034 DOI: 10.1016/j.ajo.2019.10.032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Lockwood A. Topical ocular drug delivery systems: Innovations for an unmet need. Experimental Eye Research 2022. [DOI: 10.1016/j.exer.2022.109006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Loftsson T. Topical drug delivery to the retina: obstacles and routes to success. Expert Opin Drug Deliv 2021;:1-13. [PMID: 34890514 DOI: 10.1080/17425247.2022.2017878] [Reference Citation Analysis]
3 Wakefield D, Clarke D, McCluskey P. Recent Developments in HLA B27 Anterior Uveitis. Front Immunol 2020;11:608134. [PMID: 33469457 DOI: 10.3389/fimmu.2020.608134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wong CW, Metselaar JM, Storm G, Wong TT. A review of the clinical applications of drug delivery systems for the treatment of ocular anterior segment inflammation. Br J Ophthalmol. [DOI: 10.1136/bjophthalmol-2020-315911] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]